Health News, Wellbeing Tips, Diseases, Treatment and Nutrition - The Hindu

Photo for representation only.

Health Ministry reschedules Polio National Immunisation Day to Jan. 31

Special Correspondent ‘The decision is in keeping with the stated policy of the Health Ministry to ensure that COVID-19 health services and non-COVID-19 essential health services proceed in tandem without adversely impacting each other,’ says a release

File photo for representation.

Govt defers national polio immunisation programme

Special Correspondent The country will launch its COVID-19 vaccination drive from January 16.

File photo the U.S. Supreme Court is seen in Washington. The Supreme Court has ordered that women must visit a doctor's office, hospital or clinic in person to obtain an abortion pill during the COVID-19 pandemic, though similar rules for other drugs have been suspended during the public health emergency.

U.S. justices say women must obtain abortion pill in person during pandemic

AP The pill need not be taken in the presence of medical professionals.

Fitness

See All

Are 2021’s New Year gym memberships going online?

Sunalini Mathew To some extent, say experts in the tech-led fitness and diet space, as they talk about how the COVID-19 pandemic and lockdown gave digital products a boost that’s likely to stay

Sleepless nights? Time for a reboot

8 weeks to better sleep

Sunalini Mathew The biggest takeaway from 2020: the importance of a good night’s rest. As more of us turn night owls, battling stress, isolation and work, here’s some help to reboot your routine.

Multimedia

See All

Chickens at a poultry farm at Chabba village, near Amritsar.

Watch | All about the bird flu outbreak in India

Other Articles

First
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
Last

Coronavirus | Vaccine dilemma — to take or not to take Covaxin

Health Ministry reschedules Polio National Immunisation Day to Jan. 31

Polio immunisation drive postponed

U.S. justices say women must obtain abortion pill in person during pandemic

Tardy hunt for UK variant of virus

Watch | All about the bird flu outbreak in India

‘COVID-19 herd immunity unlikely in 2021 despite vaccines’

The World Health Organization’s (WHO’s) chief scientist warned that even as numerous countries start rolling out vaccination programmes to stop

‘Adverse event surveillance is being set up in health facilities across the country’

Regulators are not taking any shortcuts on ensuring safety of COVID-19 vaccine, says NTF member N.K. Arora.

COVID-19 vaccines in less than a year — A new benchmark for human progress

It will be quite a while before we surmount the daunting challenges of funding the rollout, manufacturing the required doses and administering it to millions of people.

The Hindu Explains | How is India preparing to roll out COVID-19 vaccines?

Who is in line for a vaccine? What is Co-WIN? What is the kind of field-level mobilisation required for the drive?

The Hindu Explains | How serious is the bird flu outbreak in India, and how can it be contained?

Does bird flu pose a threat to human beings? Why does bird flu recur? Did the major outbreaks not help form strategies?

Coronavirus | Death of Bhopal volunteer not due to Covaxin, says Bharat BioTech

Case under police investigations, says pharma major.

Coronavirus | A vaccine is a vaccine... regulators never approve a backup, says virologist Shahid Jameel

Dr. Jameel says there is no experimental evidence so far that Covaxin will neutralise newly emerging mutants any better.

Coronavirus | New challenges for COVID-19 vaccine trials in India

With the daily cases coming down, many people who would have volunteered would not see the urgency now as earlier

Coronavirus | First phase of vaccination to start on January 16

Priority will be given to the healthcare workers and the frontline workers, which is estimated to be around three crore people.

Coronavirus | Use of a vaccine without knowing its protection potential is unethical, says immunologist Vineeta Bal

Dr. Bal, a former scientist of the National Institute of Immunology, says emergency use approval for COVID-19 vaccines over fears of mutant strains is not reasonable on a scientific basis.

Coronavirus | I would not take the vaccine without efficacy data: Gagandeep Kang

Even without missteps we have misinformation, warns the virologist, and any doubts can be blown up into larger conspiracy theories

Wellbeing quiz: On oral hygiene

Take this quiz on bad breath

Pfizer and BioNTech vaccine appears effective against mutation in new coronavirus variants: study

The findings of the study, though, are limited, because it does not look at the full set of mutations found in either of the new variants of the rapidly spreading virus.

Data | U.K. variant of the novel coronavirus spreads at least 50% faster than old variants

Between Dec. 30 and Jan. 5, the country registered over 800 new cases per million people on an average — the world’s highest

Coronavirus | India reports 20,346 COVID-19 cases, 222 fatalities

The number of active COVID-19 cases remained below three lakh for the 17th consecutive day

EU agency approves Moderna's COVID-19 vaccine

The EMA has already approved a coronavirus vaccine made by American drugmaker Pfizer and Germany's BioNTech. Both vaccines require giving people two shots

Stay clean, stay healthy: MicroGo bats for hygiene

Here’s how Chennai-based biotech start-up MicroGo has been focussing on making hygiene mandatory in everyday life

COVID vaccination voluntary, antibodies develop 2 weeks after second dose: AIIMS Director

On the preventive measures and precautions that one needs to follow at the session site, Dr. Guleria said one should rest at the vaccination centre for at least half an hour after taking the COVID-19

Pfizer skipped COVID-19 regulator thrice, says Ministry of Health

Its technology allows vaccines to be made relatively quickly

‘Mutation’ threat tilted balance in favour of Covaxin, meeting records show

We are perplexed at the abrupt change in thinking of the SEC, says Drug Action Network

New coronavirus strain | Total number of people infected stands at 58: Health Ministry

“All these persons have been kept in single room isolation in designated healthcare facilities by respective State governments,” the Health Ministry said

BioNTech says no data to support delayed vaccine booster shot

Germany was considering on Monday whether to allow a delay in administering the second dose to make scarce supplies gofurther after a similar move by Britain last week

‘Immunisation in a pandemic is a public good’, says public health specialist Srinath Reddy

Injectable vaccines have been designed to prevent symptomatic COVID-19 ‘disease’, not the initial viral infection, says the Public Health Foundation of India (PHFI) president

'10 million Covaxin doses ready', says Bharat Biotech chairman

The vaccine’s efficacy data will be available by March, says Krishna Ella

Total 38 samples are positive for U.K. variant of coronavirus, says Health Ministry

"Comprehensive contact tracing has been initiated for co-travellers, family contacts and others. Genome sequencing on other specimens is going on,” noted the Ministry.

Enough stockpile of COVID-19 vaccine for inoculation of priority groups in first phase: V.K. Paul

Niti Aayog member V.K. Paul noted that “three to four months from now, there will be other vaccines and the stockpile will be even bigger”.

Coronavirus | India records 16,504 new COVID-19 cases, 214 fresh fatalities

COVID-19 active caseload remained below 3 lakh for the 14th consecutive day

Coronavirus | Private hospitals keen on taking up COVID-19 vaccination

Once Pfizer and Moderna vaccines get approval, they will possibly start giving these vaccines.

Coronavirus | Experts raise questions over ‘hasty’ approval for COVID-19 vaccines

They advise against Covaxin, say there is no proof of efficacy.

Coronavirus | COVID-19 vaccination preparations done, rollout in near future: NITI Aayog member V.K. Paul

Covaxin works on the whole of the virus even with mutations, says Dr. Paul.

The three technologies helping us train for 2021

As break into a new decade, we look at the AI-driven technologies that will forge new paths from our pandemic fitness routines

Coronavirus | Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for COVID-19 vaccine

Vaccine ZyCoV-D was found to be safe, well-tolerated and immunogenic in phase I and II clinical trials

Coronavirus | India’s COVID-19 active caseload drops below 2.5 lakh: Health Ministry

Ten States/UTs account for 69.59% of new deaths

FSSAI slashes limit for trans fat levels in foods

As per the World Health Organisation, approximately 5.4 lakh deaths take place each year globally because of intake of trans fatty acids.

Coronavirus | Ready to roll out COVID-19 vaccine in India: Serum Institute of India

The company has already stockpiled around 50 million dosages of the vaccine.

Coronavirus | India approves COVID-19 vaccines Covishield and Covaxin for emergency use

This allows the vaccines to be offered to healthcare workers and frontline workers in India; Neither Covishield nor Covaxin has completed a crucial phase-3 trial in India.

The Hindu Explains | Why was a COVID-19 vaccine dry run necessary, and how was it organised?

Following the dummy run, are actual vaccines ready to be rolled out?

Coronavirus | Data on Covaxin phase-3 trials submitted to DCGI: Bharat Biotech

Publication of research awaiting peer review, says pharma major

Coronavirus | India and the race for vaccine development

Despite having several advantages, India has missed winning the race

Coronavirus | Why people with prior infection still need COVID-19 vaccination

The immune responses of people to natural infection can be modified by immune evasion mechanisms of the virus

Coronavirus | India becomes first country to culture U.K. variant strain

"U.K. variant of the virus, with all signature changes, is now successfully isolated and cultured at the National Institute of Virology (NIV) from the clinical specimens collected from UK-returnees," the ICMR said.

Coronavirus | Covaxin gets central drugs authority panel approval for restricted use

Bharat Biotech’s vaccine candidate approved for use in clinical trial mode.

First
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
Last